Home Stock

Stock Research: Towa Pharmaceutical

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Towa Pharmaceutical

TYO:4553 JP3623150004
70
  • Value
    98
  • Growth
    33
  • Safety
    Safety
    51
  • Combined
    65
  • Sentiment
    60
  • 360° View
    360° View
    70
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Towa Pharmaceutical Co Ltd manufactures and sells pharmaceuticals, primarily generic drugs, and is also involved in the research and outsourced manufacture of active pharmaceutical ingredients and soft capsules, as well as the planning, development, and contract manufacturing of health foods, general foods, and miscellaneous goods. The company is based in Japan. In the last fiscal year, the company had a market cap of $1092 millions, profits of $632 millions, revenue of $1731 millions, and 4788 employees.

more

ANALYSIS: With an Obermatt 360° View of 70 (better than 70% compared with alternatives), overall professional sentiment and financial characteristics for the stock Towa Pharmaceutical are above average. The 360° View is based on consolidating four consolidated indicators, with half of the indicators below and half above average for Towa Pharmaceutical. The consolidated Value Rank has an attractive rank of 98, which means that the share price of Towa Pharmaceutical is on the lower side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 98% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 51. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 60. But the consolidated Growth Rank has a low rank of 33, which means that the company is below average in terms of growth and momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. 67 of its competitors have better growth. ...read more

more
Strongest Rank Leverage
Weakest Rank Value
Country Japan
Industry Pharmaceuticals
Size Large
Website towayakuhin.co.jp
Index
Towa Pharmaceutical stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
98 96 100 99
Growth
33 26 63 79
Safety
Safety
51 47 37 63
Sentiment
60 68 45 37
360° View
360° View
70 72 73 91
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
48 60 63 46
Opinions Change
50 50 79 50
Pro Holdings
n/a 66 48 53
Market Pulse
48 52 11 28
Sentiment
60 68 45 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
98 96 100 99
Growth
33 26 63 79
Safety Safety
51 47 37 63
Combined
65 67 88 98
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
93 97 97 100
Price vs. Earnings (P/E)
86 97 90 100
Price vs. Book (P/B)
88 90 89 82
Dividend Yield
75 58 76 81
Value
98 96 100 99
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
37 45 46 72
Profit Growth
47 30 96 55
Capital Growth
19 4 7 5
Stock Returns
87 62 63 100
Growth
33 26 63 79
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
5 3 1 10
Refinancing
88 98 99 87
Liquidity
65 37 32 70
Safety Safety
51 47 37 63

Similar Stocks

Discover high‑ranked alternatives to Towa Pharmaceutical and broaden your portfolio horizons.

Daiwa House

TYO:1925
Country: Japan
Industry: Electric Utilities
Size: XX-Large
Full Stock Analysis

Kinden

TYO:1944
Country: Japan
Industry: Construction & Engineering
Size: X-Large
Full Stock Analysis

NGK Insulators

TYO:5333
Country: Japan
Industry: Industrial Machinery
Size: X-Large
Full Stock Analysis

Inpex

TYO:1605
Country: Japan
Industry: Oil & Gas Production
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

The stock offers good value, safe financing, and positive sentiment. However, it has below-average growth expectations. It is well-suited for conservative buy-and-hold investors who prioritize stability and low valuation over growth.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews